Electra Therapeutics
ETRA8.7105.84% ( -0.540 )
已收盘: 10月23日 16:00:00 (美东)全部股东
股东类型
- 公众及其他46.40%
- 风投/私募32.30%
- 对冲基金8.70%
- 私营企业6.05%
- 其他6.55%
主要股东
| 股东 | |||||
|---|---|---|---|---|---|
OrbiMed Advisors LLC | 10.97% | 688.52 万 | -- | +688.52 万 | |
Westlake Village BioPartners | 10.11% | 634.75 万 | -- | +634.75 万 | |
Redmile Group, LLC | 8.70% | 546.29 万 | -- | +546.29 万 | |
Lsp 7 Cooperatief U.A. | 6.05% | 379.53 万 | -- | +379.53 万 | |
EQT Life Sciences | 6.05% | 379.53 万 | -- | +379.53 万 | |
New Leaf Venture Partners, LLC | 5.18% | 324.83 万 | -- | +324.83 万 | |
Sanofi | 3.92% | 246.19 万 | -- | +246.19 万 | |
Quehuong DongPresident, CEO & Director | 0.73% | 45.55 万 | -- | +45.55 万 | |
T. Rowe Price Group, Inc. | 0.66% | 41.23 万 | -- | +41.23 万 | |
Nancy StaglianoIndependent Chair | 0.41% | 25.56 万 | -- | +25.56 万 | |
Vanguard Capital Management, LLC | 0.36% | 22.49 万 | -- | +22.49 万 | |
Columbia Management Investment Advisers, LLC | 0.20% | 12.79 万 | -- | +12.79 万 | |
Graham ParryChief Scientific Officer | 0.14% | 8.55 万 | -- | +8.55 万 | |
Gary KoeChief Technology Officer | 0.10% | 6.37 万 | -- | +6.37 万 | |
Y-Intercept (Hong Kong) Limited | 0.03% | 2.11 万 | -- | +2.11 万 | |
Vanguard Portfolio Management, LLC | <0.01% | 1,595.00 | -- | +1,595.00 | |
Matthew FustIndependent Director | 0.00% | 0.00 | -- | +0 | |
Kim-Hien DaoChief Medical Officer | 0.00% | 0.00 | -- | +0 |